Friday, October 31, 2014

Hot Heal Care Stocks To Own For 2014

Popular Posts: 5 Dividend Stocks to Help Feather Your Easter BasketTop 10 Dow Dividend Stocks for AprilTrade of the Day: ON Semiconductor (ONNN) Recent Posts: Top 10 Dow Dividend Stocks for April Trade of the Day: ON Semiconductor (ONNN) 5 Dividend Stocks to Help Feather Your Easter Basket View All Posts

Sixteen weeks into 2014, the Dow, Nasdaq and Russell 2000 are all down year-to-date, while the S&P 500 is only ahead by about 1.5%. The market is dealing with some genuine obstacles that weren’t prevalent at the end of 2013, as worries over Russia’s annexation of Ukraine, slowing in China’s economy, Japan’s anemic exports, deflationary pressure in Europe and Fed tapering are weighing on investor sentiment.

Best Services Companies To Invest In 2015: Marathon Petroleum Corp (MPC)

Marathon Petroleum Corporation (MPC), incorporated on November 9, 2009, is a petroleum product refiners, transporters and marketers in the United States. The Company operates in three segments: Refining & Marketing, Speedway and Pipeline Transportation. Marathon Petroleum�� refining, marketing and transportation operations are concentrated in the Midwest, Gulf Coast and Southeast regions of the United States. MPC has two retail brands: Speedway and Marathon. Effective as of June 30, 2011, MPC was separated from Marathon Oil Corporation (Marathon Oil) and became an independent company in a spin-off transaction.

Refining & Marketing

The Company owned and operated six refineries in the Gulf Coast and Midwest regions of the United States with an aggregate crude oil refining capacity of approximately 1.2 million barrels per calendar day as of December 31, 2011. During 2011, its refineries processed 1,177 million barrels per day of crude oil and 181 mbpd of other charge and blend stocks. Its refineries include crude oil atmospheric and vacuum distillation, fluid catalytic cracking, catalytic reforming, desulfurization and sulfur recovery units. The refineries process a range of crude oils and produce numerous refined products, ranging from transportation fuels, such as reformulated gasolines, blend-grade gasolines intended for blending with fuel ethanol and ultra-low-sulfur diesel fuel, to heavy fuel oil and asphalt. Additionally, MPC manufacture aromatics, propane, propylene, cumene and sulfur.

The Company�� Garyville, Louisiana refinery is located along the Mississippi River in southeastern Louisiana between New Orleans and Baton Rouge. The Garyville refinery is configured to process heavy sour crude oil into products, such as gasoline, distillates, asphalt, polymer grade propylene, propane, isobutane, sulfur and fuel-grade coke. The Catlettsburg, Kentucky refinery is located in northeastern Kentucky on the western bank of the Big Sandy River, near the confluence! with the Ohio River. The Catlettsburg refinery processes sweet and sour crude oils into products such as gasoline, distillates, asphalt, cumene, petrochemicals, propane and propylene. The Robinson, Illinois refinery is located in southeastern Illinois. The Robinson refinery processes sweet and sour crude oils into products, such as multiple grades of gasoline, distillates, anode-grade coke, propane, butane and propylene.

MPC�� Detroit, Michigan refinery is located near Interstate 75 in southwest Detroit. It is the petroleum refinery operating in Michigan. The Detroit refinery processes light sweet and heavy sour crude oils, including Canadian crude oils, into products, such as gasoline, distillates, asphalt, slurry, propane, and propylene. Its Canton, Ohio refinery is located approximately 60 miles southeast of Cleveland, Ohio. The Canton refinery processes sweet and sour crude oils into products such as gasoline, distillates, asphalt, propane, slurry and roofing flux. Its Texas City, Texas refinery is located on the Texas Gulf Coast approximately 30 miles south of Houston, Texas. The refinery processes sweet crude oil into products such as gasoline, chemical grade propylene, propane, slurry and aromatics.

As of December 31, 2011, the Company owned and operated 62 light product and 21 asphalt terminals. In addition, it distributes through approximately 52 third-party light product and 12 third-party asphalt terminals in its market area. During 2011, marine transportation operations included 15 towboats, as well as 167 owned and 14 leased barges that transport refined products on the Ohio, Mississippi and Illinois rivers and their tributaries, as well as the Intercoastal Waterway. As of December 31, 2011, the Company leased or owned approximately 1,950 railcars of various sizes and capacities for movement and storage of refined products. In addition, it own 124 transport trucks for the movement of refined products.

The Company produces propane at all six of its! refineri! es. Propane is primarily used for home heating and cooking, as a feedstock within the petrochemical industry, for grain drying and as a fuel for trucks and other vehicles. The Company is also a producer and marketer of feedstocks and specialty products. Product availability varies by refinery and includes propylene, cumene, dilute naphthalene oil, molten sulfur, toluene, benzene and xylene. Propane is primarily used for home heating and cooking, as a feedstock within the petrochemical industry, for grain drying and as a fuel for trucks and other vehicles.

Speedway

The Company sells transportation fuels and convenience products in the retail market in the Midwest, primarily through Speedway convenience stores. The Speedway segment sells gasoline and merchandise through convenience stores that the Companu owns and operates, primarily under the Speedway brand. Speedway-branded convenience stores offer a range of merchandise, such as prepared foods, beverages and non-food items, including a number of private-label items. As of December 31, 2011, Speedway had 1,371 convenience stores in seven states.

Pipeline Transportation

The Company transports crude oil and other feedstocks to our refineries and other locations, delivers refined products to wholesale and retail market areas and includes, among other transportation-related assets, a majority interest in LOOP LLC, which is the owner and operator of the United States deepwater oil port. It owns common carrier pipeline systems through Marathon Pipe Line LLC (MPL) and Ohio River Pipe Line LLC (ORPL), both of which are wholly owned subsidiaries. These pipeline systems transport crude oil and refined products, primarily in the Midwest and Gulf Coast regions, to its refineries, its terminals and other pipeline systems. The Company�� MPL and ORPL wholly owned carrier systems consist of 1,707 miles of crude oil lines and 1,825 miles of refined product lines comprising 31 systems located in 11 states, as of Decem! ber 31, 2! 011. In addition, MPL leases and operates 217 miles of common carrier refined product pipelines.

The common carrier refined product pipelines include the owned and operated Cardinal Products Pipeline and the Wabash Pipeline. The Cardinal Products Pipeline delivers refined products from Kenova, West Virginia, to Columbus, Ohio. The Wabash Pipeline system delivers refined products from Robinson, Illinois, to various terminals in the area of Chicago, Illinois. Other refined product pipelines owned and operated by MPL extend from: Robinson, Illinois to Louisville, Kentucky; Robinson, Illinois to Lima, Ohio; Wood River, Illinois to Indianapolis, Indiana; Garyville, Louisiana to Zachary, Louisiana, and Texas City, Texas to Pasadena, Texas.

As of December 31, 2011, the Company had partial ownership interests in the pipeline companies that have approximately 110 miles of crude oil pipelines and 3,600 miles of refined products pipelines, including about 970 miles operated by MPL, which include Centennial Pipeline LLC (Centennial), Explorer Pipeline Company (Explorer), LOCAP LLC (LOCAP), LOOP LLC (LOOP), Muskegon Pipeline LLC (Muskegon) and Wolverine Pipe Line Company (Wolverine).

The Company holds a 50% interest in Centennial, which owns a refined products pipeline system connecting the Gulf Coast region with the Midwest market. The Company holds a 17% interest in Explorer, a refined products pipeline system extending from the Gulf Coast to the Midwest. It holds a 51% interest in LOOP, the owner and operator of the Louisiana Offshore Oil Port, which is a deepwater oil port capable of receiving crude oil from large crude carriers, located 18 miles off the coast of Louisiana, and a crude oil pipeline connecting the port facility to storage caverns and tanks at Clovelly, Louisiana. The Company holds a 60% interest in Muskegon, which owns a refined products pipeline extending from Griffith, Indiana to North Muskegon, Michigan. It hold a 6% interest in Wolverine, a refined prod! ucts pipe! line system extending from Chicago, Illinois to Toledo, Ohio.

Advisors' Opinion:
  • [By Ben Levisohn]

    Now that Marathon Petroleum (MPC), Phillips 66 (PSX) and Valero Energy (VLO) have reported earnings, Citigroup has decided it’s time to take a step back and consider where the big three might be headed.

    ASSOCIATED PRESS

    Higher, say Faisel Khan and Mohit Bhardwaj. They write:

    [Marathon Petroleum], [Phillips 66] and [Valero Energy] all present upsides from current levels. We believe that [Marathon Petroleum],�[Valero Energy] and�[Phillips 66] are equally well positioned to grow their midstream assets.�[Marathon Petroleum] and�[Phillips 66] have their midstream assets positioned in the US while�[Valero Energy] has some assets outside of the US which are less attractive from an MLP perspective.�[Phillips 66] also has a significant position in Chemicals and in gathering & processing NGLs. However, we believe that from a refining perspective�[Valero Energy] & [Marathon Petroleum] are best suited to capture the advantage from the growing crude production in the US. [Valero Energy]remains our preferred name followed by�[Marathon Petroleum] and [Phillips 66].

    Shares of Valero Energy have gained 0.5% to $51.69 today at 2:24 p.m., while Marathon Petroleum has risen 0.8% to $88.16 and Phillips 66 is up 0.2% at $73.71.

  • [By Claudia Assis]

    Refiner Valero Energy Corp. (VLO) �topped gainers among energy companies in the S&P 500 index, with shares up 3.7%. Coal producer Consol Energy Inc. (CNX) �was not too far behind, with shares up 2.1%. Marathon Petroleum Corp. (MPC) �rose 1.9%.

  • [By Dan Caplinger]

    Marathon Petroleum (NYSE: MPC  ) , down 13.6%
    Refinery stocks across the industry have performed well and been an important part of the S&P's long-term rally, but last month, they gave up ground as the spreads between U.S. and foreign crude prices started to narrow. An even more serious threat to Marathon and its peers comes from new environmental laws that will require extensive capital expenditures to comply. For Marathon to start moving higher again, it needs to see spreads start to widen again and for heightened energy use to keep prices up while still getting cheap oil from the U.S. oil patch.

  • [By Claudia Assis]

    Among a handful of gainers, Marathon Petroleum Corp. (MPC) �shares advanced 1.3%.

Hot Heal Care Stocks To Own For 2014: ChemoCentryx Inc (CCXI)

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The Company targets the chemokine system, a network of molecules, including chemokine ligands and their associated receptors, as well as related chemo-attractant receptors, all of which are known to drive inflammation. As of December 31, 2011, the Company had four drug candidates in clinical development. Its drug candidates include Traficet-EN (CCX282, GSK'786 or vercirnon), CCX140, CCX354, CCX168, CCX872, CCX507 and CCX662. The Company is also advancing several additional independent drug candidates through preclinical development. The Company�� wholly owned subsidiary is ChemoCentryx Limited.

The Company's drug candidate Traficet-EN (CCX282, GSK'786), is to control the inflammatory response underlying IBD by targeting the chemokine receptor known as CCR9. The Company has completed nine clinical trials with Traficet-EN in a total of 785 subjects, including five Phase I clinical trials (three in the United States and two in the United Kingdom), one thorough QT study in the United States (an assessment of cardiovascular safety which is required for regulatory approval), and three Phase II clinical trials (one in the Netherlands, the United Kingdom, and the United States, one in Finland and one (PROTECT-1) in Australia, Austria, Belgium, Brazil, Bulgaria, Canada, the Czech Republic, Denmark, France, Germany, Hungary, Israel, the Netherlands, Poland, South Africa, Sweden and the United Kingdom). As of December 31, 2011, the Company�� Traficet-EN drug candidate is in four pivotal Phase III clinical trials being conducted by its partner Glaxo Group Limited (GSK).

The Company's independent drug candidate CCX140, targets the chemokine receptor known as CCR2. CCX140 is a potent and selective antagonist of CCR2 that is found on subsets of monocytes and macrophages, which are cells of th! e immune system. In January 2011, the Company completed a 159-patient randomized Phase II clinical trial, conducted in Australia, the Czech Republic, Germany, Hungary and New Zealand, to assess the safety and tolerability of CCX140 in patients with type 2 diabetes. In addition, CCX140 demonstrated biological activity through a dose-dependent decrease in fasting plasma glucose.

CCX354 targets the chemokine receptor known as CCR1. Synovial fluid from the joints of rheumatoid arthritis (RA) patients contains high levels of activated CCR1 chemokine ligands. The Company completed two Phase I clinical trials in a total of 84 healthy subjects, conducted in Switzerland followed by a Phase I/II clinical trial in 24 patients with stable RA, conducted in Belgium and Romania, and a Phase II proof-of-concept clinical trial in 160 patients with moderate-to-severe RA, conducted in Belgium, the Czech Republic, Germany, Hungary, Poland, Romania and the Ukraine. GSK exercised its option to further develop and commercialize CCX354 in November 2011 and had an exclusive right to initiate a Phase II b clinical trial for CCX354 in RA.

CCX168 targets the chemo-attractant C5a receptor (C5aR), which binds to a biologically activated fragment of the complement protein known as C5. As of December 31, the Company completed a Phase I clinical trial for CCX168, conducted in Switzerland. The Company initiated a Phase II proof-of-concept clinical trial in AAV in the fourth quarter of 2011. Its CCX872 is an independent next generation CCR2 drug candidate for the treatment of metabolic diseases, its CCX507 is an independent drug candidate for the treatment of inflammatory bowel disease (IBD) and CCX662 is an independent drug candidate for the treatment of glioblastoma multiforme (GBM).

The Company competes with Abbott Laboratories, Amgen Inc, AstraZeneca plc, Biogen Idec Inc, Bayer AG, Elan Corporation plc, Glaxo Group Limited, Merck & Co Inc, Merck Serono, Takeda Pharmaceutical Co Ltd, Novartis AG! , Pfizer ! Inc, Reata Pharmaceuticals, Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb, Incyte Corp and UCB Pharma.

Advisors' Opinion:
  • [By CRWE]

    ChemoCentryx, Inc. (Nasdaq:CCXI), reported that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, September 7, 2012, at 9:30 a.m. Eastern Time at the Millennium Broadway Hotel & Conference Center in New York, NY.

  • [By James E. Brumley]

    The last few weeks haven't been particularly encouraging for Crohn's disease sufferers. In August, GlaxoSmithKline (NYSE: GSK) and ChemoCentryx (NASDAQ:CCXI) reported that a jointly-developed Crohn's drug, vercirnon, had failed to meet its late-stage trial endpoints. Though the in-development drug isn't dead in the water (GSK and CCXI could rework the drug, the testing regimen, or use it for other indications), it doesn't look good. Then this month - just a few days ago - Coronado Biosciences Inc. (NASDAQ:CNDO) reported that its Phase 3 trials of Crohn's disease drug TSO had also failed to meet its primary endpoints as well. Like vercirnon, CNDO isn't completely out of luck here with the treatment, but forging ahead with further development of the treatment is grasping at straws. Crohn's sufferers don't need to give up home just yet, however - TNI Biotech Inc. (OTCMKTS:TNIB) appears to have a Crohn's treatment that works, and should be able to sidestep the problems that plagued ChemoCentryx, GlaxoSmithKline, and Coronado Biosciences.

Hot Heal Care Stocks To Own For 2014: (TELNY)

Telenor ASA operates as a telecommunication company worldwide. It provides mobile communication, fixed line communication, and television (TV)-based services. The company?s mobile communication services include voice, data, Internet, content, and electronic commerce services, as well as customer equipment, such as telephone sets, mobile phones, smart phones, computers, and PABX?s. Its fixed line services comprise analogue PSTN, digital ISDN, broadband telephony, xDSL, Internet, and leased lines, as well as communication solutions. The company?s TV-based services consist of pay-TV services via satellite dish, cable TV-networks, satellite master antenna TV-networks systems, broadband access services to cable TV-subscribers, and broadcasting rights, as well as security solutions to pay-TV operators. It also provides consulting and information technology services; maritime and aircraft telecommunications services; Internet protocol services; and mobile marketing agency service s, as well as manages two funds. The company has approximately 120 million mobile subscriptions. Telenor ASA was founded in 1885 and is headquartered in Fornebu, Norway.

Advisors' Opinion:
  • [By Charles Sizemore]

    Next Page

    European Dividend Stocks to Buy: Telenor ASA (TELNY)

    Dividend Yield: 5.3%

    Norwegian telecom operator Telenor (TELNY) has exactly what I like to see in ��merging markets lite��dividend stocks. It�� headquartered in a well-regulated European market, and it has a large-enough market presence in developed markets to provide a level of stability. Norway accounts for 24% of revenues, with other European markets (primarily Sweden and Denmark, though Telenor has significant operations in Hungary, Serbia. Montenegro and Bulgaria as well) making up another 24%.

Hot Heal Care Stocks To Own For 2014: LCNB Corp (LCNB)

LCNB Corp. (LCNB), incorporated on December 12, 1998, is a financial holding company. The Company�� principal activity is the ownership of LCNB National Bank (the Bank). The Bank is a full service community bank offering a range of commercial and personal banking services. Deposit services include checking accounts, negotiable order of withdrawal (NOW) accounts, savings accounts, Christmas and vacation club accounts, money market deposit accounts, Classic 50 accounts (a senior citizen program), individual retirement accounts, and certificates of deposit. Loan products offered include commercial and industrial loans, commercial and residential real estate loans, construction loans, various types of consumer loans, and Small Business Administration loans. In January 2014, Eaton National Bank & Trust Co. merged with LCNB Corp.'s wholly-owned subsidiary, LCNB National Bank.

The Bank's residential mortgage lending activities consist primarily of loans for purchasing or refinancing personal residences, home equity lines of credit, and loans for commercial or consumer purposes secured by residential mortgages. Consumer lending activities include automobile, boat, home improvement and personal loans. The Bank also offers indirect financing through various automotive, boat, and lawn and garden dealers. The Trust and Investment Management Division of the Bank performs complete trust administrative functions and offers agency and trust services, retirement savings products, and mutual fund investment products to individuals, partnerships, corporations, institutions and municipalities.

Security brokerage services are offered by the Bank through arrangements with LPL Financial LLC, a registered broker/dealer. Licensed brokers offer a full range of investment services and products, including financial needs analysis, mutual funds, securities trading, annuities, and life insurance.

Other services offered include safe deposit boxes, night depositories, travelers' checks, money! orders, cashier's checks, bank-by-mail, automated teller machines (ATMs), cash and transaction services, debit cards, wire transfers, electronic funds transfer, utility bill collections, notary public service, personal computer based cash management services, around-the-clock telephone banking, PC Internet banking, and other services tailored for both individuals and businesses. LCNB�� primary market area consists of Warren, Butler, and Clinton Counties and portions of Hamilton, Clermont and Montgomery Counties in Southwestern Ohio.

Advisors' Opinion:
  • [By Lisa Levin]

    LCNB (NASDAQ: LCNB) shares touched a new 52-week low of $16.57. LCNB shares have dropped 4.80% over the past 52 weeks, while the S&P 500 index has gained 18.57% in the same period.

Hot Heal Care Stocks To Own For 2014: Louisiana-Pacific Corp (LPX)

Louisiana-Pacific Corporation, incorporated on July 20, 1972, is a manufacturer of building products. The Company operates in four segments: North America Oriented Strand Board (OSB); Siding; Engineered Wood Products (EWP), and South America. As of December 31, 2012, the Company owned 21 modern located facilities in the United States and Canada, two facilities in Chile and one facility in Brazil. The Company also operates three facilities through joint ventures, for which it is the provider of product distribution for North America and participate in a joint venture operation that produces cellulose insulation in multiple facilities. The Company�� products are used primarily in new home construction, repair and remodeling, and manufactured housing. In May 2013, Canfor Corp announced that it has completed the sale of its 50% interest in the Peace Valley Oriented Strand Board (OSB) joint venture in Fort St. John, B.C., to Louisiana-Pacific Corp (LP).

OSB

The Company�� OSB segment manufactures and distributes OSB structural panel products. OSB is a smart product made from wood strands arranged in layers and bonded with resin. OSB serves many of the same uses as plywood, including roof decking, sidewall sheathing and floor underlayment. During the year ended December 31, 2012, OSB accounted for approximately 58% of the structural panel consumption in North America.

Siding

The Company�� siding offerings are of two categories: SmartSide siding products and related accessories; and CanExel siding and accessory products. Its SmartSide products consist of a line of wood-based sidings, trim, soffit and fascia. Its CanExel siding and accessory product offerings include a number of pre-finished lap and trim products in a variety of patterns and textures. Additionally, minor amounts of commodity OSB are produced and sold in this segment.

Engineered Wood Products

The Company�� Engineered Wood Products (EWP) segment manufactures! and distributes laminated veneer lumber (LVL), I-Joists, laminated strand lumber (LSL) and other related products. This segment also includes the sale of I-Joist produced by its joint venture with Resolute Forest Products (formerly AbitibiBowater) and LVL sold under a contract manufacturing arrangement.

South America

The Company�� South American segment manufactures and distributes OSB and siding products in South America and certain export markets. This segment also distributes and sells related products to augment the transition to wood frame construction.

Other Products

The Company�� other products category includes its decorative moulding and its joint venture that produces cellulose insulation. Additionally, it other products category includes its remaining timber and timberlands, and other minor products, services and closed operations.

Advisors' Opinion:
  • [By Lisa Levin]

    This industry declined 2.76% by 11:00 am, with Louisiana-Pacific (NYSE: LPX) moving down 2.4%. Louisiana-Pacific shares have dropped 23.18% over the past 52 weeks, while the S&P 500 index has gained 16.68% in the same period.

Hot Heal Care Stocks To Own For 2014: Microvision Inc.(MVIS)

MicroVision, Inc. engages in the development of miniature laser display and imaging engines based upon its proprietary PicoP display engine technology. Its technology uses two dimensional micro-electrical mechanical systems, lasers, optics, and electronics to create a video or still image from a small form factor device. The company offers Pico projector displays intended to be used for users of mobile consumer devices, such as smartphones, media players, tablet PCs, and other consumer electronics products. Its products also comprise automotive head-up displays that project high-resolution images onto the windshield of an automobile providing the driver with information consisting of GPS mapping images, audio controls, and other automobile instrumentation information related to the car's operation. In addition, the company offers near-eye wearable display platform to provide personal viewing of information from a mobile device through a wired or wireless connection. Furthe r, it offers ROV hand held bar code scanners, and bar code scanner enabled enterprise solutions through distributors and original equipment manufacturers, as well as directly to end users through its online store. The company serves customers operating in the consumer, defense, industrial, and medical markets. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

Advisors' Opinion:
  • [By James E. Brumley]

    Did you miss the first big runup from Microvision, Inc. (NASDAQ:MVIS) a couple of weeks ago? If you were regretting it then, it may have all worked out for the best. Though MVIS jumped from a close of $1.35 on the 19th to a peak of $3.38 on the 21st, it was also on the 21st that the weight of that big gain started to bear down. By the 25th, Microvision shares hit a low of $2.01, basically cutting in half the 150% gain that has been made in just a couple of days.

No comments:

Post a Comment